Acambis plc (London: ACM)
Cambridge
CB1 9PT, United Kingdom (Map) Phone: +44-1223-275-300
Fax: +44-1223-416-300
Primary US Office:
Subscribers Only http://www.acambis.com
Overview
Acambis stands firmly in the "ounce of prevention" camp. The UK biopharmaceutical company specializes in vaccines that protect against infectious diseases. The US government contracted Acambis to build its stockpile of smallpox vaccine (ACAM2000) as concerns about bio-terrorism proliferated following September 11. Under those contracts, the company produced ACAM2000 while it was still an investigational drug; however, the FDA gave it the regulatory nod in 2007. Acambis produces the vaccine for other governments as well, and it is developing non-biodefense vaccines for diseases such as encephalitis, flu, and West Nile virus. The company agreed to be acquired by Sanofi Pasteur in 2008.
Sample Overview
Key Numbers from Hoover's UK
Key financials for Acambis plc (London: ACM)
| Company Type | Public (London: ACM; Pink Sheets: ACAMY) |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Acambis plc (London: ACM)
| VP, Business Development | Alan Lamont (Subscribers see complete biographies -- view sample)
Connect to this executive |
|---|---|
| CFO | Elizabeth Jones Connect to this executive |
| VP, Sales and Marketing | Christian Loucq Connect to this executive |
Top Competitors from Hoover's UK
Top competitors of Acambis plc (London: ACM)
There are 17 competitors for Acambis; see more.Significant Developments
View company events at Acambis plc (London: ACM) such as IPOs, bankruptcies, or executive changes
| Event | Details |
|---|---|
| Top Executive Change | Subscribers get full details -- view a sample |
| Exchange/Ticker Change |
